Levetiracetam in Meige's syndrome.
The spontaneous occurrence of blepharospasm and dystonic movements in face muscles, particularly those of the perioral and mandibular regions, has been named as Meige's disease which was first described by Henry Meige in 1910. We report the case of a woman with Meige's syndrome whose symptoms improved with the use of levetiracetam.
Yardimci
N
N
Neurology Department, Faculty of Medicine, Baskent University, Ankara, Turkey. ntuncel@yahoo.com
Karatas
M
M
Kilinc
M
M
Benli
S
S
D000927:Anticonvulsants / Q000008:administration & dosage*; D019274:Botulinum Toxins, Type A / Q000009:adverse effects; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D006970:Disorders of Excessive Somnolence / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004576:Electromyography / Q000187:drug effects; D005152:Facial Muscles / Q000294:innervation / Q000503:physiopathology*; D005260:Female; D006801:Humans; D007473:Ion Channels / Q000187:drug effects / Q000378:metabolism; D000077287:Levetiracetam; D008538:Meige Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D018832:Molecular Chaperones / Q000235:genetics; D010889:Piracetam / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D000927:Anticonvulsants; D007473:Ion Channels; D018832:Molecular Chaperones; C108175:TOR1A protein, human; D000077287:Levetiracetam; D019274:Botulinum Toxins, Type A; D010889:Piracetam